Gut-friendly diet linked to lower mortality risk in coronary heart disease
View as a Web Page
News Medical
 
  Cardiology Cardiology logo  
  The latest cardiology news from News Medical  
 Semaglutide dose may matter more than weight loss for heart healthSemaglutide dose may matter more than weight loss for heart health
 
The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging existing treatment assumptions.
 
 
 Gut-friendly diet linked to lower mortality risk in coronary heart diseaseGut-friendly diet linked to lower mortality risk in coronary heart disease
 
Using NHANES 2005-2018 data, researchers found that adults with coronary heart disease who had higher Dietary Index for Gut Microbiota scores had lower all-cause mortality risk. The association was nonlinear, strongest when scores reached 5 or higher, and remained observational rather than causal.
 
   Study links GLP-1 treatment to fewer alcohol drinking daysStudy links GLP-1 treatment to fewer alcohol drinking days
 
Current GLP-1 receptor agonist prescriptions were associated with modestly lower AUDIT-C scores in a large, diverse US cohort. The difference appeared to reflect less frequent drinking rather than fewer drinks per occasion or fewer binge-drinking episodes.
 
   GLP-1RAs linked to lower risk of amputation in diabetes with PADGLP-1RAs linked to lower risk of amputation in diabetes with PAD
 
Research indicates GLP-1RAs may decrease limb complications in type 2 diabetes with PAD, though more randomized studies are required to confirm efficacy.
 
   Most hospital readmissions after heart failure are not heart-relatedMost hospital readmissions after heart failure are not heart-related
 
A study reveals that non-cardiovascular medications increase hospital readmission risks in heart failure patients, highlighting the need for better management.
 
 Updated ABCs framework gives clinicians a clearer path to prevent heart disease
 
Updated ABCs framework gives clinicians a clearer path to prevent heart diseaseA 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in routine care. The framework emphasizes PREVENT™ risk equations, Life’s Essential 8, CKM syndrome, obesity care, lipid lowering, blood pressure control, healthy aging, heart failure prevention, and atrial fibrillation management.
 
 
 New model improves short- and long-term disease risk prediction
 
New model improves short- and long-term disease risk predictionResearchers developed ALADYNOULLI, a Bayesian generative model that combines longitudinal health records, age, and polygenic risk to identify reproducible disease signatures across more than 683,000 participants. In UK Biobank testing, the framework achieved stronger short- and long-term risk discrimination than established clinical scores while revealing disease subgroups and genetic associations.
 
 
 Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference
 
Semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk differenceResearchers compared semaglutide with liraglutide in 57,456 insured adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management. Semaglutide users had a lower risk of incident diabetes, particularly beyond six months of follow-up, but limited cardiovascular events prevented a precise comparison of cardiovascular risk.
 
 
 Global hotspots where breast cancer and atrial fibrillation overlap
 
Global hotspots where breast cancer and atrial fibrillation overlapInvestigating breast cancer and atrial fibrillation overlap, this study highlights key risk factors, underscoring the need for integrated prevention approaches.
 
 
 New molecular mechanism identified in common inherited heart disease
 
New molecular mechanism identified in common inherited heart diseaseA study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an international research team, has identified a new molecular mechanism involved in hypertrophic cardiomyopathy, the most common inherited cardiovascular disease.
 
 
 Gum disease bacteria linked to calcific aortic valve stenosis
 
Gum disease bacteria linked to calcific aortic valve stenosisGum disease bacteria may spur calcium buildup in the heart's aortic valve, leading to a common and serious heart valve disease, according to preliminary, independent research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026.
 
 
 Micro and nanoplastics in the blood linked to increased heart attack risk factors
 
Micro and nanoplastics in the blood linked to increased heart attack risk factorsPeople who have suffered a serious heart attack had higher levels of micro and nanoplastics in their blood, compared to patients diagnosed with chronic ischemic heart disease and those who have normal blood vessels supplying the heart, according to a study published in the European Heart Journal today (Wednesday).
 
 
 Healthcare barriers impact survival rates for adult congenital heart disease
 
Healthcare barriers impact survival rates for adult congenital heart diseasePeople with congenital heart disease living in states with low household incomes and limited access to health insurance and the specialized care they need may be more likely to become disabled or die from congenital heart disease, according to new, independent research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.
 
 
 DNA Nanotechnology May Open New Paths to Stroke Repair
 
DNA Nanotechnology May Open New Paths to Stroke RepairThis review examines how programmable DNA nanostructures may support stroke repair by enabling targeted delivery, neuroprotection, biosensing, imaging, gene regulation, and tissue regeneration. The authors conclude that DNA nanotechnology is a promising preclinical platform, but clinical translation still depends on improving stability, safety, biodistribution, and scalable manufacturing.
 
 
 Female Hearts Rely on Molecular Safeguard to Avoid Failure
 
Female Hearts Rely on Molecular Safeguard to Avoid FailureMen and women are not born with the same risk of heart disease, and for decades scientists have struggled to explain why. A new study from the University of North Carolina at Chapel Hill, published in Genes & Development, offers a striking answer: the female heart depends on a molecular safeguard that the male heart can largely do without - and when that safeguard is removed, female hearts fail while male hearts keep beating.
 
 
 Crucial X Chromosome Protein Protects Female Hearts From Fatal Failure
 
Crucial X Chromosome Protein Protects Female Hearts From Fatal FailureMen and women are not born with the same risk of heart disease, and for decades scientists have struggled to explain why.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026